
Newron Pharmaceuticals has announced the approval for its ENIGMA-TRS phase 3 development programme evaluating evenamide as an add-on therapy to …

Women who have used oral contraceptives as teenagers are more likely to experience depression later in life, according to a …

Japanese drugmaker Sunovion Pharmaceuticals has made their current Chief Medical Officer (CMO) the company’s new Chief Executive Officer (CEO). Dr …

Nerve stimulation treatments can significantly improve depressed people’s quality of life, even in cases in which an individual continues to …

Research undertaken by the Royal College of Psychiatrists using data from NHS Digital has found that the number of psychiatrists …
Boehringer Ingelheim has announced it will collaborate on a new three-year programme to investigate the neural foundations of psychiatric disorders. …
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation

